Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rituximab maintenance therapy for patients with antineutrophil cytoplasmic antibody-associated vasculitis in Japan.
Takeyama Y, Ono N, Shirahama Y, Inoue Y, Tanaka A, Ueda N, Nishimura N, Nagano S, Uchino A, Miyamura T, Oryoji K, Inoue H, Maruyama A, Ota SI, Yoshizawa S, Sawabe T, Himuro N, Miyake K, Kimoto Y, Horiuchi T, Mitoma H, Niiro H, Takamori A, Tada Y. Takeyama Y, et al. Among authors: kimoto y. Mod Rheumatol. 2021 Mar;31(2):408-416. doi: 10.1080/14397595.2020.1790778. Epub 2020 Jul 27. Mod Rheumatol. 2021. PMID: 32615836
Molecular analysis of a novel hereditary C3 deficiency with systemic lupus erythematosus.
Tsukamoto H, Horiuchi T, Kokuba H, Nagae S, Nishizaka H, Sawabe T, Harashima S, Himeji D, Koyama T, Otsuka J, Mitoma H, Kimoto Y, Hashimura C, Kitano E, Kitamura H, Furue M, Harada M. Tsukamoto H, et al. Among authors: kimoto y. Biochem Biophys Res Commun. 2005 Apr 29;330(1):298-304. doi: 10.1016/j.bbrc.2005.02.159. Biochem Biophys Res Commun. 2005. PMID: 15781264
A functional M196R polymorphism of tumour necrosis factor receptor type 2 is associated with systemic lupus erythematosus: a case-control study and a meta-analysis.
Horiuchi T, Kiyohara C, Tsukamoto H, Sawabe T, Furugo I, Yoshizawa S, Ueda A, Tada Y, Nakamura T, Kimoto Y, Mitoma H, Harashima S, Yoshizawa S, Shimoda T, Okamura S, Nagasawa K, Harada M. Horiuchi T, et al. Among authors: kimoto y. Ann Rheum Dis. 2007 Mar;66(3):320-4. doi: 10.1136/ard.2006.058917. Epub 2006 Oct 6. Ann Rheum Dis. 2007. PMID: 17028114 Free PMC article. Review.
A dose-escalation study of rituximab for treatment of systemic lupus erythematosus and Evans' syndrome: immunological analysis of B cells, T cells and cytokines.
Tamimoto Y, Horiuchi T, Tsukamoto H, Otsuka J, Mitoma H, Kimoto Y, Nakashima H, Muta K, Abe Y, Kiyohara C, Ueda A, Nagasawa K, Yoshizawa S, Shimoda T, Harada M. Tamimoto Y, et al. Among authors: kimoto y. Rheumatology (Oxford). 2008 Jun;47(6):821-7. doi: 10.1093/rheumatology/ken071. Epub 2008 Apr 8. Rheumatology (Oxford). 2008. PMID: 18397955 Clinical Trial.
Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.
Kimoto Y, Horiuchi T, Tsukamoto H, Kiyohara C, Mitoma H, Uchino A, Furugo I, Yoshizawa S, Ueda A, Harashima S, Sawabe T, Tahira T, Hayashi K, Yoshizawa S, Shimoda T, Akashi K, Harada M. Kimoto Y, et al. Rheumatology (Oxford). 2010 Jul;49(7):1346-53. doi: 10.1093/rheumatology/keq050. Epub 2010 Apr 5. Rheumatology (Oxford). 2010. PMID: 20371502
285 results